EN | ΕΛ
Browse Helios by "Author"
Jump to a point in the index:
Or type in a year:
Sort by: In order: Results/Page
Showing results 1 to 16 of 16

DateTitleAuthor(s)Full text
2006Comparison of proposed putative bioactive conformations of altered peptide ligands of myelin basic protein by spectroscopic and modelling studiesMantzourani, F. D.; Mavromoustakos, Thomas; Golic-Grdadolnik, S.; Platts, J. A.; Deraos, G. N.; Matsoukas, J. M.; Tselios, T. V.
2006Comparison of proposed putative active conformations of myelin basic protein epitope 87-99 linear altered peptide ligands by spectroscopic and modelling studies: The role of positions 91 and 96 in T-cell receptor activationMantzourani, E. D.; Tselios, T. V.; Grdadolnik, S. G.; Platts, J. A.; Brancale, A.; Deraos, G. N.; Matsoukas, J. M.; Mavromoustakos, Thomas
2006A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg(91), Ala(96)] MBP87-99Mantzourani, E. D.; Tselios, T. V.; Grdadolnik, S. G.; Brancale, A.; Platts, J. A.; Matsoukas, J. M.; Mavromoustakos, Thomas
2005Exploration of conformational space of linear EAE antagonist [Arg(,)(91) Ala(96)] MBP87-99 and proposal of a putative bioactive conformation in DMSO-d(6).Mantzourani, E. D.; Tselios, T. V.; Golic-Grdadolnik, S.; Matsoukas, J. M.; Brancale, A.; Platts, J. A.; Mavromoustakos, T. M.
2005Structural requirements for binding of Myelin Basic Protein (MBP) peptides to MHC II: Effects on immune regulationMantzourani, E. D.; Mavromoustakos, Thomas; Platts, J. A.; Matsoukas, J. M.; Tselios, T. V.
2003Conformational and biological studies for a pair of novel synthetic AT(1) antagonists: stereoelectronic requirements for antihypertensive efficacyZoumpoulakis, Panagiotis; Zoga, A.; Roumelioti, P.; Giatas, N.; Grdadolnik, S. G.; Iliodromitis, E.; Vlahakos, D.; Kremastinos, D.; Matsoukas, J. M.; Mavromoustakos, Thomas
2000The design and synthesis of a potent Angiotensin II cyclic analogue confirms the ring cluster receptor conformation of the hormone Angiotensin IIMatsoukas, J. M.; Polevaya, L.; Ancans, J.; Mavromoustakos, Thomas; Kolocouris, A.; Roumelioti, P.; Vlahakos, D. V.; Yamdagni, R.; Wu, Q.; Moore, G. J.
2000Structural comparison between type I and type II antagonists: Possible implications in the drug design of AT1 antagonistsRoumelioti, P.; Tselios, T.; Alexopoulos, K.; Mavromoustakos, Thomas; Kolocouris, A.; Moore, G. J.; Matsoukas, J. M.
1999Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: Importance of the Ala(81) carboxyl group and of at cyclic conformation for induction of experimental allergic encephalomyelitisTselios, T.; Probert, L.; Daliani, I.; Matsoukas, E.; Troganis, A.; Gerothanassis, I. P.; Mavromoustakos, Thomas; Moore, G. J.; Matsoukas, J. M.
1997Structure elucidation and conformational analysis of gonadotropin releasing hormone and its novel synthetic analogue [Tyr(OMe)5, D-LyS6, Aze9NHEt]GnRH: The importance of aromatic clustering in the receptor binding activityMatsoukas, J. M.; Keramida, M.; Panagiotopoulos, D.; Mavromoustakos, Thomas; Maia, H. L. S.; Bigam, G.; Pati, D.; Habibi, H. R.; Moore, G. J.
1996Superimposition of potent non-peptide AT(1) receptor antagonists with angiotensin IITheodoropoulou, E.; Mavromoustakos, Thomas; Panagiotopoulos, D.; Matsoukas, J. M.; Smith, J.
1996Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: Importance of the Phe/Arg relative conformation and the primary amino group for activityMatsoukas, J. M.; Panagiotopoulos, D.; Keramida, M.; Mavromoustakos, Thomas; Yamdagni, R.; Wu, Q.; Moore, G. J.; Saifeddine, M.; Hollenberg, M. D.
1996Interactions of angiotensin II with membranes using a combination of differential scanning calorimetry and P-31 NMR spectroscopyMavromoustakos, Thomas; Theodoropoulou, E.; Dimitriou, C.; Matsoukas, J. M.; Panagiotopoulos, D.; Makriyannis, A.
1996Synthesis and activities of cyclic thrombin-receptor-derived peptide analogues of the Ser(42)-Phe-Leu-Leu-Arg(46) motif sequence containing D-Phe and/or D-ArgPanagiotopoulos, D.; Matsoukas, J. M.; Alexopoulos, K.; Zebeki, A.; Mavromoustakos, Thomas; Saifeddine, M.; Hollenberg, M. D.
1995Differences in Backbone Structure between Angiotensin-Ii Agonists and Type-I AntagonistsMatsoukas, J. M.; Agelis, G.; Wahhab, A.; Hondrelis, J.; Panagiotopoulos, D.; Yamdagni, R.; Wu, Q.; Mavromoustakos, Thomas; Maia, H. L. S.; Ganter, R.; Moore, G. J.
1994Role of the Nh2-Terminal Domain of Angiotensin-Ii (Ang-Ii) and [Sar(1)]Angiotensin-Ii on Conformation and Activity - Nmr Evidence for Aromatic Ring Clustering and Peptide Backbone Folding Compared with [Des-1,2,3]Angiotensin-IiMatsoukas, J. M.; Hondrelis, J.; Keramida, M.; Mavromoustakos, Thomas; Makriyannis, A.; Yamdagni, R.; Wu, Q.; Moore, G. J.
Showing results 1 to 16 of 16



 

Follow EKT at: